What Iron Tests Should Men on TRT Get? (TRT Q&As)
Timeline
Timestamp
Topic
01:00
Which iron studies should I order to properly monitor my blood while on testosterone?
Dr. O’Connor explains the iron testing he wants men on androgens to obtain, including ferritin, total iron, TIBC, and iron saturation. He discusses using these results alongside the CBC to understand red blood cell and iron status rather than relying on hematocrit alone.
Dr. O’Connor explains the iron testing he wants men on androgens to obtain, including ferritin, total iron, TIBC, and iron saturation. He discusses using these results alongside the CBC to understand red blood cell and iron status rather than relying on hematocrit alone.
04:40
Is blood donation or therapeutic phlebotomy required or recommended for men on TRT?
A member provides a hematocrit of 52.4%, high-normal hemoglobin, low-normal ferritin, and elevated iron saturation. Dr. O’Connor explains that the decision to remove blood must be individualized because unnecessary phlebotomy can further lower ferritin, while cardiovascular and clotting history also affect the risk assessment.
A member provides a hematocrit of 52.4%, high-normal hemoglobin, low-normal ferritin, and elevated iron saturation. Dr. O’Connor explains that the decision to remove blood must be individualized because unnecessary phlebotomy can further lower ferritin, while cardiovascular and clotting history also affect the risk assessment.
08:30
What can I do if testosterone keeps raising my red blood cells even after lowering my dose?
Dr. O’Connor says more information is needed before deciding how to manage the elevated red blood cells, including the complete CBC, ferritin, iron saturation, and other iron studies. He also emphasizes evaluating cardiovascular disease, venous thromboembolism history, and other health risks rather than treating a single laboratory value.
Dr. O’Connor says more information is needed before deciding how to manage the elevated red blood cells, including the complete CBC, ferritin, iron saturation, and other iron studies. He also emphasizes evaluating cardiovascular disease, venous thromboembolism history, and other health risks rather than treating a single laboratory value.
10:20
Can I use TRT after receiving a kidney transplant?
Dr. O’Connor says TRT can be considered after a kidney transplant and discusses his experience with men who have undergone transplantation. He emphasizes coordination with the transplant team and careful monitoring, particularly because the underlying kidney disease and overall medical history matter.
Dr. O’Connor says TRT can be considered after a kidney transplant and discusses his experience with men who have undergone transplantation. He emphasizes coordination with the transplant team and careful monitoring, particularly because the underlying kidney disease and overall medical history matter.
13:40
Do I really need to stop testosterone and steroids because my red blood cell count and hematocrit are high?
A member says his doctor warned him about stroke and heart attack after finding a hematocrit around 51% while he had been using testosterone and Deca. Dr. O’Connor says the available numbers alone are not enough to assess his risk and wants additional information including hemoglobin, iron studies, age, cardiovascular history, and his complete androgen regimen.
A member says his doctor warned him about stroke and heart attack after finding a hematocrit around 51% while he had been using testosterone and Deca. Dr. O’Connor says the available numbers alone are not enough to assess his risk and wants additional information including hemoglobin, iron studies, age, cardiovascular history, and his complete androgen regimen.
17:30
Should I be worried about starting TRT if my LDL cholesterol is 131?
A 41-year-old man considering TRT asks about an LDL of 131 and total cholesterol of 217 despite years of dieting and training. Dr. O’Connor discusses cardiovascular risk assessment and coronary calcium testing, emphasizing that the more important issue is identifying and managing underlying atherosclerotic risk rather than viewing testosterone as the only concern.
A 41-year-old man considering TRT asks about an LDL of 131 and total cholesterol of 217 despite years of dieting and training. Dr. O’Connor discusses cardiovascular risk assessment and coronary calcium testing, emphasizing that the more important issue is identifying and managing underlying atherosclerotic risk rather than viewing testosterone as the only concern.
Video Summary
This mailbag discussion addresses questions about side effects that may arise during testosterone therapy. It explains that some changes are expected as the body adapts, while others warrant closer attention. Side effects are framed as signals to interpret rather than immediate reasons for alarm.
A central portion discusses how timing, dose stability, and individual sensitivity influence side effect perception. The episode emphasizes distinguishing transient adaptation effects from persistent concerns. Contextual evaluation is highlighted to guide appropriate response.
The closing segment reinforces the importance of communication and monitoring when side effects occur. Proportional responses, ongoing observation, and structured follow-up are emphasized. Hormone therapy is positioned as requiring vigilance without overreaction.
Drug Callouts
Drug
Description
Testosterone
Testosterone is an androgen hormone used therapeutically to treat confirmed testosterone deficiency and related symptoms. In this mailbag episode, testosterone therapy is discussed in relation to side effect awareness and management.
Condition Callouts
Condition
Description
Testosterone deficiency
Testosterone deficiency is a clinical condition characterized by low circulating testosterone levels with associated symptoms. It is referenced as the indication for therapy while emphasizing side effect evaluation.
Key Takeaways
- Some side effects reflect normal adaptation to therapy.
- Timing helps distinguish transient from persistent effects.
- Contextual evaluation supports better decisions.
- Proportional responses reduce unnecessary concern.
- Ongoing follow-up improves safety during therapy.